4//SEC Filing
Sjuts Dustin S 4
Accession 0001209191-22-019707
CIK 0001479290other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:43 PM ET
Size
5.0 KB
Accession
0001209191-22-019707
Insider Transaction Report
Form 4
Sjuts Dustin S
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2022-03-15$15.79/sh−1,835$28,975→ 97,123 total
Footnotes (1)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on March 15, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of Restricted Stock award (the "RSA") for 22,620 shares. The RSA vests in three equal annual installments from March 15, 2021, subject to Mr. Sjuts' Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001796224
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 5:43 PM ET
- Size
- 5.0 KB